Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Restructuring Costs: 2021-2025

Historic Restructuring Costs for Collegium Pharmaceutical (COLL) over the last 2 years, with Sep 2025 value amounting to $10.9 million.

  • Collegium Pharmaceutical's Restructuring Costs rose 39.88% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year increase of 50.89%. This contributed to the annual value of $33.7 million for FY2024, which is 4.27% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Restructuring Costs stood at $10.9 million for Q3 2025, which was up 11.26% from $9.8 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Restructuring Costs high stood at $13.3 million for Q1 2025, and its period low was $4.6 million during Q4 2021.
  • Moreover, its 2-year median value for Restructuring Costs was $9.5 million (2024), whereas its average is $9.7 million.
  • Data for Collegium Pharmaceutical's Restructuring Costs shows a peak YoY skyrocketed of 54.11% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Collegium Pharmaceutical's Restructuring Costs stood at $4.6 million in 2021, then reached $9.5 million in 2024, then surged by 39.88% to $10.9 million in 2025.
  • Its Restructuring Costs was $10.9 million in Q3 2025, compared to $9.8 million in Q2 2025 and $13.3 million in Q1 2025.